US Archives - Page 106 of 118 - European Medical Journal

New Drugs in Oncology

The 2024 American Society of Clinical Oncology (ASCO) Annual Meeting showcased groundbreaking advancements in oncology, with…

ASCO 2024 Interview: Michael A. Postow

Immunotherapy with drugs like nivolumab and ipilimumab has been decades in the making, even long before our group at MSK was involved. The…

Dr Erika Hamilton

Director of Breast Cancer Research Program; Chair, Executive Breast Committee; Sarah Cannon Research Institute, Nashville, Tennessee, USA…

EMJ

Prof Brian van Tine

Professor of Medicine and Pediatrics, Division of Oncology, Section of Medical Oncology, Washington University School of Medicine…

EMJ

Dr Caroline Michie

Consultant Medical Oncologist, Edinburgh Cancer Centre; Honorary Clinical Senior Lecturer, University of Edinburgh, Scotland, UK…

EMJ

Dr Samir Parekh

Professor of Medicine and and Oncological Sciences; Icahn School of Medicine at Mount Sinai, New York City, New York, USA…

EMJ

Dr Pooja Advani

Consultant and Assistant Professor of Medicine, Mayo Clinic, Jacksonville, Florida, USA…

EMJ

Dr Nicolò Battisti

Consultant Medical Oncologist, The Royal Marsden NHS Foundation Trust, London, UK…

EMJ

Dr Roberto Leon-Ferre

Consultant, Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota…

EMJ

Prof Daniel McFarland

Director, Psycho-Oncology Program, Wilmot Cancer Center, The University of Rochester Medical Center, Rochester, New York, USA…